MAPT and Cognitive impairment: Correspondingly, reduced CSF levels of amyloid-beta1_42 and/or elevated CSF levels of total-tau and phospho-tau have been reported to be associated with cognitive impairment in sporadic PD (Brockmann et al., 2015a, 2017; Kang et al., 2016; Lerche et al., 2019b).